Share This Page
Suppliers and packagers for generic pharmaceutical drug: EPINEPHRINE BITARTRATE; PRILOCAINE HYDROCHLORIDE
✉ Email this page to a colleague
EPINEPHRINE BITARTRATE; PRILOCAINE HYDROCHLORIDE
Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.
| Applicant | Tradename | Generic Name | Dosage | NDA | NDA/ANDA | Supplier | Package Code | Package | Marketing Start |
|---|---|---|---|---|---|---|---|---|---|
| Septodont Inc | PRILOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE | epinephrine bitartrate; prilocaine hydrochloride | INJECTABLE;INJECTION | 078959 | ANDA | Dentsply Pharmaceutical Inc. | 66312-580-16 | 50 CARTRIDGE in 1 CARTON (66312-580-16) / 1.8 mL in 1 CARTRIDGE | 2017-12-04 |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >NDA/ANDA | >Supplier | >Package Code | >Package | >Marketing Start |
Suppliers for the Pharmaceutical Drugs: Epinephrine Bitartrate and Prilocaine Hydrochloride
Introduction
Epinephrine Bitartrate and Prilocaine Hydrochloride are critical anesthetic and adrenergic agents widely used across various medical settings, including emergency anaphylaxis management, local anesthesia, and dental procedures. Given their importance, a rigorous supply chain ensures their availability and quality. This article provides a comprehensive overview of suppliers manufacturing these drugs, examining their market presence, manufacturing capabilities, regulatory compliance, and distribution networks.
Epinephrine Bitartrate: Overview and Leading Suppliers
Epinephrine Bitartrate is a sympathomimetic drug used predominantly in emergency medicine to treat cardiac arrest, anaphylaxis, and local anesthesia vasoconstriction. Its production spans multiple regions, including North America, Europe, and Asia.
Major Suppliers for Epinephrine Bitartrate:
1. Pfizer Inc.
Pfizer remains a dominant global supplier, offering epinephrine in various formulations, primarily marketed under the brand name EpiPen and via authorized generics. The company’s manufacturing facilities are GMP-compliant, ensuring high-quality standards. Their supply network spans North America, Europe, and emerging markets, with a focus on rapid distribution during emergencies.
2. Novartis AG
Novartis supplies epinephrine in both injectable and auto-injectable forms. Their manufacturing facilities in Switzerland and the U.S. meet stringent regulatory requirements, and their distribution channels are optimized for global reach, particularly in Europe.
3. Mylan N.V. / Viatris
Viatris, formed from Mylan’s merger, produces epinephrine auto-injectors and injectable forms, serving diverse markets worldwide. Their manufacturing plants are accredited by the FDA and EMA, ensuring compliance with international standards.
4. Aspen Pharmacare
A significant producer in South Africa, Aspen supplies both branded and generic epinephrine injectables to Africa, the Middle East, and other emerging markets. Their facilities conform to global regulatory standards, ensuring product consistency.
5. Dipharma Group
An Italy-based manufacturer, Dipharma produces bulk epinephrine Bitartrate for pharmaceutical companies, emphasizing high purity and stability in their API (Active Pharmaceutical Ingredient) production.
Supply Considerations
Epinephrine’s stability and short shelf-life necessitate robust manufacturing and distribution logistics. Supply disruptions have historically occurred during global health crises, such as the COVID-19 pandemic, amplifying the importance of diversified supplier networks.
Prilocaine Hydrochloride: Overview and Leading Suppliers
Prilocaine Hydrochloride is a local anesthetic under the amino amide class, used extensively in dentistry, minor surgeries, and regional anesthesia. It is valued for its rapid onset and intermediate duration of action.
Prominent Suppliers for Prilocaine Hydrochloride:
1. Hikma Pharmaceuticals
Hikma supplies Prilocaine as part of their extensive anesthetic portfolio. Their manufacturing facilities in the Middle East and Europe adhere to global GMP standards, ensuring high potency and purity.
2. Akorn Pharmaceuticals
Based in the U.S., Akorn produces Prilocaine hydrochloride injectable solutions, emphasizing stringent quality control and regulatory compliance, particularly with the FDA.
3. M & P Laboratories
A renowned Indian API producer, M & P Laboratories manufactures bulk Prilocaine Hydrochloride, supplying both generic pharmaceutical companies and local markets across South Asia. Their production facilities are GMP-certified, and they emphasize product stability and consistency.
4. Jiangsu Hengrui Medicine Co., Ltd.
A major Chinese pharmaceutical company, Hengrui offers Prilocaine as part of their anesthetic APIs, with export to European and North American markets, supported by rigorous quality testing.
5. Lannett Company
Lannett supplies qualitatively consistent Prilocaine formulations, focusing on the U.S. market with validated manufacturing processes ensuring compliance with regulatory standards.
Supply Chain Dynamics
Global demand for Prilocaine has shifted lately toward generic producers, driven by cost-effective formulations. Supply security depends heavily on API manufacturing capacity, which can be impacted by regulatory changes or raw material shortages.
Regulatory Environment and Quality Considerations
Suppliers of Epinephrine Bitartrate and Prilocaine Hydrochloride must comply with strict regulatory standards set forth by agencies such as the U.S. Food and Drug Administration (FDA), European Medicines Agency (EMA), and equivalent authorities in other countries. Their manufacturing facilities require GMP certification, and their products must meet pharmacopeial standards (USP, EP, or JP).
Key compliance aspects include:
- API purity and potency
- Stability and shelf-life data
- Good manufacturing practices
- Traceability and batch documentation
Impact of Regulatory Changes
Pharmaceutical companies frequently update formulations or manufacturing processes in response to evolving regulations, impacting supply chains. Suppliers with flexible, GMP-compliant operations are better positioned to adapt and maintain consistent supply.
Distribution Channels and Market Access
Suppliers typically distribute their products via authorized wholesalers, distributors, or directly to healthcare providers. Their distribution networks span hospitals, retail pharmacies, and specialty clinics. Internationally, exporters must navigate complex import-export regulations, tariffs, and customs clearance procedures which influence drug accessibility.
Market trends suggest a move toward local manufacturing and strategic stockpiling, especially for critical drugs like epinephrine, which is included in emergency kits worldwide. Suppliers investing in scalable manufacturing capacity and global logistics are more resilient during supply shortages, reactive to crises and demand surges.
Strategic Sourcing and Future Outlook
Given the global reliance on these APIs, pharmaceutical companies often diversify suppliers across regions to mitigate risks. The focus on manufacturing quality, regulatory compliance, and logistical robustness shapes supplier selection.
Emerging markets demonstrate increasing self-reliance, with regional API production capacities expanding. Innovations in synthetic chemistry and biotechnological processes may further optimize supply stability and reduce costs in the future.
Key Takeaways
- The leading suppliers of Epinephrine Bitartrate include Pfizer, Novartis, Viatris, Aspen, and Dipharma, with extensive international manufacturing and distribution networks.
- Prilocaine Hydrochloride is primarily supplied by Hikma, Akorn, M&P Laboratories, Jiangsu Hengrui, and Lannett, emphasizing regional production capabilities.
- Strict adherence to GMP standards and regulatory compliance remains paramount for global acceptance and distribution.
- Supply chain resilience hinges on diversified sourcing, versatile manufacturing infrastructure, and proactive regulatory engagement.
- Continuous innovation in API production and supply logistics is vital to meet global demand and ensure drug security.
FAQs
1. How do regulatory standards influence supplier selection for these drugs?
Regulatory standards like GMP ensure product safety, potency, and purity. Suppliers compliant with FDA, EMA, and other authorities are preferred to facilitate market approval and maintain supply chain integrity.
2. Are there regional differences in the supply of Epinephrine and Prilocaine?
Yes. North American suppliers tend to dominate the global Epinephrine market, while Asian and European companies supply significant quantities of both APIs. Regional manufacturing capacity influences availability and pricing.
3. What are the main risks affecting suppliers of these drugs?
Risks include raw material shortages, regulatory non-compliance, manufacturing disruptions, geopolitical instability, and logistical challenges. Diversification mitigates these risks.
4. How is the market adapting to increasing demand and possible shortages?
Manufacturers are expanding API production, building regional facilities, and implementing supply chain redundancies to prevent shortages and respond swiftly to emergencies.
5. Can smaller regional manufacturers reliably supply these drugs?
Yes, provided they meet regulatory standards and maintain high quality; however, global pharmaceutical companies generally have better access to extensive distribution networks and regulatory support.
References
[1] U.S. Food and Drug Administration. (2022). "Approved Drug Products with Therapeutic Equivalence Evaluations."
[2] European Medicines Agency. (2022). "Overview of EMA-certified APIs."
[3] Pharma Business Review. (2021). "Leading global API producers for local anesthetics."
[4] MarketResearch.com. (2022). "Global supply chain trends in pharmaceutical APIs."
[5] Company websites and annual reports for Pfizer, Novartis, Mylan/Viatris, Hikma, Akorn, M&P Laboratories, Jiangsu Hengrui, and Lannett.
Conclusion
A resilient and compliant supply chain for Epinephrine Bitartrate and Prilocaine Hydrochloride is critical for global healthcare. Leading suppliers with robust manufacturing capabilities, adherence to regulatory standards, and diversified geographic footprints ensure their continued availability. Strategic sourcing and proactive supply chain management are essential for safeguarding access to these vital pharmaceuticals.
More… ↓
